Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-15

Clinical Trial Update: Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 trial investigating combined steroid and cyclosporin as first-line treatment for adults with immune thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporin (cyclosporine)
  • Steroid (steroid)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN